Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: June 07, 2022 Report Code: GDME1374EPD-ST

Select Item

Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. These analyzers are typically offered in modular increments, which can operate independently or simultaneously as a unit. Analyzers covered under this category include chemiluminescence analyzers, immunofluorescence analyzers, and enzyme immunoassay (EIA) analyzers.

The immunochemistry analyzers pipeline market research report provides comprehensive information about the immunochemistry analyzers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides key insights on major pipeline products, including product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

Key Segments in Immunochemistry Analyzers Pipeline Products Market

Immunofluorescence Analyzers, Enzyme Immunoassay Analyzers, Chemiluminescence Analyzers, and Bench-Top POC Analyzers are the key segments covered in the immunochemistry analyzers pipeline market research report. Immunofluorescence Analyzers hold the largest market share.

Immunochemistry Analyzers Pipeline Products Market, by Segments

Immunochemistry Analyzers Pipeline Products Market, by Segments

For more segment insights, download a free report sample

Key Regions for the Immunochemistry Analyzers Pipeline Products Market

United States, Europe, Canada, China, South Korea, Singapore, Australia, India, Japan, and Nigeria have products in the pipeline. The US has the highest number of products in the pipeline out of all these territories.

Immunochemistry Analyzers Pipeline Products Market, by Regions

Immunochemistry Analyzers Pipeline Products Market, by Regions

For more territorial insights, download a free report sample

Key Regulatory Paths for the Immunochemistry Analyzers Pipeline Products Market

The regulatory paths followed by the immunochemistry analyzers pipeline products include 510(k), CE-IVD, MDITAC, NMPA, CE, HSA, ICAC, MDL, Ninsho, CLIA, BL, and TGA. Most of the products follow the 510(k) pathway to enter the market.

Immunochemistry Analyzers Pipeline Products Market, by Regulatory Path

Immunochemistry Analyzers Pipeline Products Market, by Regulatory Path

For more regulatory path insights, download a free report sample

Key Companies in the Immunochemistry Analyzers Pipeline Products Market

Some of the key companies in the immunochemistry analyzers pipeline products market are Atonomics A/S (Inactive), Beckman Coulter Inc, Biosan Medical Ltd, Boditech Med Inc, Boston University, BreviTest Technologies LLC, China Medical Technologies Inc (Inactive), ChipCare Corp, Clearbridge BioLoc Pte Ltd, Corgenix Medical Corp, DiaSorin SpA, Drew Scientific Co Ltd, Dyamed Biotech Pte Ltd, and Enigma Diagnostics Ltd (Inactive).

Market Report Overview

Key Segments Immunofluorescence Analyzers, Enzyme Immunoassay (EIA) Analyzers, Chemiluminescence Analyzers, and Bench-Top POC Analyzers
Key Territories United States, Europe, Canada, China, South Korea, Singapore, Australia, India, Japan, and Nigeria
Key Regulatory Paths 510(k), CE-IVD, MDITAC, NMPA, CE, HSA, ICAC, MDL, Ninsho, CLIA, BL, and TGA
Key Companies Atonomics A/S (Inactive), Beckman Coulter Inc, Biosan Medical Ltd, Boditech Med Inc, Boston University, BreviTest Technologies LLC, China Medical Technologies Inc (Inactive), ChipCare Corp, Clearbridge BioLoc Pte Ltd, Corgenix Medical Corp, DiaSorin SpA, Drew Scientific Co Ltd, Dyamed Biotech Pte Ltd, and Enigma Diagnostics Ltd (Inactive)

Scope

This report provides:

  • Extensive coverage of the immunochemistry analyzers under development
  • The report reviews details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of immunochemistry analyzers and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of immunochemistry analyzers under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Astek Diagnostics
Atonomics A/S (Inactive)
Beckman Coulter Inc
Biosan Medical Ltd
BioSIMS
Boditech Med Inc
Boston University
BreviTest Technologies LLC
China Medical Technologies Inc (Inactive)
ChipCare Corp
Clearbridge BioLoc Pte Ltd
Corgenix Medical Corp
DiaSorin SpA
Drew Scientific Co Ltd
Dyamed Biotech Pte Ltd
Enigma Diagnostics Ltd (Inactive)
Euroimmun AG
Firalis SAS
GenapSys Inc
Genevo Biosystems Pte Ltd
Great Basin Scientific Inc.
HeatFlow Technologies Inc
Hokkaido University
Huakang Biomedical Holdings Co Ltd
Indian Institute of Technology Madras
Johnson & Johnson
LabNow Inc (Inactive)
Lucerna Inc
Magellan Diagnostics Inc
MedNostic Technologies, LLC
Merck Millipore Corp
Meridian Bioscience Inc
NanoLab Inc
Ortho Clinical Diagnostics Holdings Plc
PerkinElmer Inc
Protomex Life Sciences
Randox Laboratories Ltd
Rapid Diagnostek, Inc.
Siloam Biosciences, Inc.
Spectradyne LLC
Tecan Group Ltd
The Palo Alto Research Center
Tyncbest Biotechnology
University of Illinois at Urbana-Champaign
University of Michigan Pediatric Device Consortium
University of South Florida
University of Southern California
Virogenomics BioDevelopment Inc
Xanthostat Diagnostics Inc
Yunnan Energy International Co Ltd

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 12

2 Introduction 13

2.1 Immunochemistry Analyzers Overview 13

3 Products under Development 14

3.1 Immunochemistry Analyzers – Pipeline Products by Stage of Development 14

3.2 Immunochemistry Analyzers – Pipeline Products by Segment 15

3.3 Immunochemistry Analyzers – Pipeline Products by Territory 16

3.4 Immunochemistry Analyzers – Pipeline Products by Regulatory Path 17

3.5 Immunochemistry Analyzers – Pipeline Products by Estimated Approval Date 18

4 Immunochemistry Analyzers – Pipeline Products under Development by Companies 19

4.1 Immunochemistry Analyzers Companies – Pipeline Products by Stage of Development 19

4.2 Immunochemistry Analyzers – Pipeline Products by Stage of Development 21

5 Immunochemistry Analyzers Companies and Product Overview 23

5.1 Astek Diagnostics Company Overview 23

5.1.1 Astek Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Atonomics A/S (Inactive) Company Overview 24

5.2.1 Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Beckman Coulter Inc Company Overview 25

5.3.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Biosan Medical Ltd Company Overview 26

5.4.1 Biosan Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 BioSIMS Company Overview 27

5.5.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Boditech Med Inc Company Overview 28

5.6.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Boston University Company Overview 32

5.7.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 32

5.8 BreviTest Technologies LLC Company Overview 33

5.8.1 BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 33

5.9 China Medical Technologies Inc (Inactive) Company Overview 34

5.9.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34

5.10 ChipCare Corp Company Overview 35

5.10.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 Clearbridge BioLoc Pte Ltd Company Overview 36

5.11.1 Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 Corgenix Medical Corp Company Overview 37

5.12.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 37

5.13 DiaSorin SpA Company Overview 38

5.13.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Drew Scientific Co Ltd Company Overview 39

5.14.1 Drew Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Dyamed Biotech Pte Ltd Company Overview 40

5.15.1 Dyamed Biotech Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Enigma Diagnostics Ltd (Inactive) Company Overview 41

5.16.1 Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

5.17 Euroimmun AG Company Overview 42

5.17.1 Euroimmun AG Pipeline Products & Ongoing Clinical Trials Overview 42

5.18 Firalis SAS Company Overview 44

5.18.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 44

5.19 GenapSys Inc Company Overview 45

5.19.1 GenapSys Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.20 Genevo Biosystems Pte Ltd Company Overview 48

5.20.1 Genevo Biosystems Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.21 Great Basin Scientific Inc. Company Overview 49

5.21.1 Great Basin Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

5.22 HeatFlow Technologies Inc Company Overview 50

5.22.1 HeatFlow Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 Hokkaido University Company Overview 51

5.23.1 Hokkaido University Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 Huakang Biomedical Holdings Co Ltd Company Overview 52

5.24.1 Huakang Biomedical Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.25 Indian Institute of Technology Madras Company Overview 53

5.25.1 Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 53

5.26 Johnson & Johnson Company Overview 54

5.26.1 Johnson & Johnson Pipeline Products & Ongoing Clinical Trials Overview 54

5.27 LabNow Inc (Inactive) Company Overview 55

5.27.1 LabNow Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

5.28 Lucerna Inc Company Overview 56

5.28.1 Lucerna Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.29 Magellan Diagnostics Inc Company Overview 57

5.29.1 Magellan Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.30 MedNostic Technologies, LLC Company Overview 58

5.30.1 MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58

5.31 Merck Millipore Corp Company Overview 59

5.31.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 59

5.32 Meridian Bioscience Inc Company Overview 60

5.32.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.33 NanoLab Inc Company Overview 61

5.33.1 NanoLab Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.34 Ortho Clinical Diagnostics Holdings Plc Company Overview 63

5.34.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 63

5.35 PerkinElmer Inc Company Overview 64

5.35.1 PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.36 Protomex Life Sciences Company Overview 65

5.36.1 Protomex Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 65

5.37 Randox Laboratories Ltd Company Overview 66

5.37.1 Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.38 Rapid Diagnostek, Inc. Company Overview 67

5.38.1 Rapid Diagnostek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67

5.39 Siloam Biosciences, Inc. Company Overview 68

5.39.1 Siloam Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

5.40 Spectradyne LLC Company Overview 69

5.40.1 Spectradyne LLC Pipeline Products & Ongoing Clinical Trials Overview 69

5.41 Tecan Group Ltd Company Overview 70

5.41.1 Tecan Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

5.42 The Palo Alto Research Center Company Overview 71

5.42.1 The Palo Alto Research Center Pipeline Products & Ongoing Clinical Trials Overview 71

5.43 Tyncbest Biotechnology Company Overview 72

5.43.1 Tyncbest Biotechnology Pipeline Products & Ongoing Clinical Trials Overview 72

5.44 University of Illinois at Urbana-Champaign Company Overview 73

5.44.1 University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview 73

5.45 University of Michigan Pediatric Device Consortium Company Overview 74

5.45.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 74

5.46 University of South Florida Company Overview 75

5.46.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 75

5.47 University of Southern California Company Overview 76

5.47.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 76

5.48 Virogenomics BioDevelopment Inc Company Overview 77

5.48.1 Virogenomics BioDevelopment Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.49 Xanthostat Diagnostics Inc Company Overview 78

5.49.1 Xanthostat Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.50 Yunnan Energy International Co Ltd Company Overview 79

5.50.1 Yunnan Energy International Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

6 Immunochemistry Analyzers- Recent Developments 80

6.1 May 13, 2022: Siemens to exit Russia over invasion of Ukraine; takes €600m hit 80

6.2 May 12, 2022: Siemens Strong operational performance and growth ended March 31, 2022 80

6.3 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference 82

6.4 May 12, 2022: Siemens Announces Q2 FY 2022 results 82

6.5 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company 83

6.6 May 11, 2022: IsoPlexis Reports First Quarter 2022 Financial Results 83

6.7 May 11, 2022: Babson, BD expand strategic partnership to advance diagnostic blood collection in new care settings 84

6.8 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix 85

6.9 May 04, 2022: Ortho Clinical Diagnostics Reports First Quarter 2022 Results 86

6.10 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference 87

6.11 Apr 29, 2022: BD to Present at the BofA Securities 2022 Healthcare Conference 87

6.12 Apr 28, 2022: Novacyt Full year 2021 results and update on growth strategy 87

6.13 Apr 25, 2022: EKF Diagnostics Holdings announces Posting of Annual Report & Accounts &Notice of AGM 89

6.14 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference 90

6.15 Apr 20, 2022: Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022 90

6.16 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results 90

6.17 Apr 12, 2022: Tecan announce Annual General Meeting 2022 91

6.18 Apr 12, 2022: BIO-TECHNE and Cygnus Technologies, part of Maravai LifeSciences, introduce new simple plex HEK 293 HCP 3G immunoassay 92

6.19 Apr 11, 2022: Thermo Fisher Scientific to Host Investor Day 93

6.20 Apr 11, 2022: IsoPlexis Reports Preliminary First Quarter 2022 Revenue, Streamlines Operating Structure to Support Sustainable Growth 93

6.21 Apr 07, 2022: Quidel Announces Preliminary Revenue for First Quarter 2022 94

6.22 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference 95

6.23 Apr 06, 2022: BioPorto Notice Convening the Annual General Meeting 95

6.24 Mar 15, 2022: Tecan closes transformative year with substantial growth in sales and net profit 95

6.25 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results 99

6.26 Mar 14, 2022: Qiagen Announces 20-f Annual Report Filing for 2021 Results 100

6.27 Mar 09, 2022: Bioasis to Attend and Present at Upcoming Industry Conference 100

6.28 Mar 01, 2022: Cardiff Oncology to Participate in Cowen’s 42nd Annual Healthcare Conference 100

6.29 Feb 25, 2022: Bio-Rad presents growth strategy and acceleration of financial targets at investor day 101

6.30 Feb 24, 2022: BD to Present at the Cowen 42nd Annual Health Care Conference 101

6.31 Feb 23, 2022: embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD 102

6.32 Feb 23, 2022: Bd Appoints Shana Neal as Chief People Officer 102

6.33 Feb 16, 2022: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results 102

6.34 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors 104

6.35 Feb 14, 2022: Bio-Rad Laboratories to Post Q1 2022 Earnings of $2.80 Per Share, Jefferies Financial Group Forecasts 104

6.36 Feb 14, 2022: Horiba announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2021 104

6.37 Feb 11, 2022: KAIST develops rapid bacterial detection method using deep learning 105

6.38 Feb 11, 2022: Span Divergent Un-Audited Financial Results for the Quarter Ended 31st December 2021 106

6.39 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference 106

6.40 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference 106

6.41 Feb 02, 2022: Bio-Rad to Host Investor Day on February 25 107

6.42 Jan 31, 2022: EKF Diagnostics Holdings Announces Non-executive Directorate Change 107

6.43 Jan 27, 2022: Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference 108

6.44 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results 108

6.45 Jan 11, 2022: Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs 109

6.46 Jan 11, 2022: SDI Group Announces Board Change 110

6.47 Jan 07, 2022: Quidel Announces Preliminary Revenue for Fourth Quarter 2021 110

6.48 Jan 06, 2022: BD Announces Change to Virtual 2022 Annual Meeting of Shareholders 111

6.49 Jan 05, 2022: BD to announce financial results for its first quarter of fiscal year 2022 112

6.50 Jan 04, 2022: Halo Collective appoints Sky Pinnick as chief marketing officer 112

6.51 Jan 03, 2022: Ortho Clinical Diagnostics to Participate in the 40th Annual JP Morgan Healthcare Conference 113

6.52 Jan 02, 2022: Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021 113

6.53 Dec 21, 2021: BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business 114

6.54 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results 116

6.55 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference 117

6.56 Dec 07, 2021: SDI Group Announces Interim results for the six months ended 31 October 2021 117

6.57 Dec 07, 2021: SDI Group – Interim Results for the six months ended 31 October 2021 118

6.58 Nov 29, 2021: Bioasis Announces Annual General Meeting Details 119

6.59 Nov 26, 2021: Mitsubishi Chemical Holdings Notice of Changes Regarding the Corporate Executive Officer and Chief Financial Officer 120

6.60 Nov 23, 2021: EKF Diagnostics Holdings Appoints Marc Davies as Chief Financial Officer 120

6.61 Nov 23, 2021: Biolidics Announces Appointment of Independent Director 121

6.62 Nov 22, 2021: RD-Biotech expands antibody and immunoassay services with xMAP Technology 121

6.63 Nov 15, 2021: BioPorto Announces Extraordinary General Meeting and New Board Member 122

6.64 Nov 12, 2021: Psychemedics Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021 122

6.65 Nov 11, 2021: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2021 124

6.66 Nov 10, 2021: Sysmex announces Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2022 125

6.67 Nov 10, 2021: Sysmex Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2021, and Revision of Full-Year Financial Forecasts 127

6.68 Nov 04, 2021: Quidel Reports Third Quarter 2021 Financial Results 128

6.69 Nov 04, 2021: Cardiff Oncology Reports Third Quarter 2021 Results and Provides Business Updates 130

6.70 Oct 29, 2021: Halo Collective announces “Budega” as name for retail store brand, appoints new retail senior vice president 133

6.71 Oct 26, 2021: BD to Host Investor Day on November 12 133

6.72 Oct 20, 2021: BioPorto appoints new Chief Executive Officer and announces changes to the Board of Directors 134

6.73 Oct 20, 2021: BioPorto appoints new Chief Financial Officer 134

6.74 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021 135

6.75 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations 136

6.76 Oct 12, 2021: Ortho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021 137

6.77 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference 137

6.78 Oct 07, 2021: Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021 137

6.79 Oct 01, 2021: Mitsubishi Chemical Holdings announces Personnel Personnel Changes 138

6.80 Sep 30, 2021: Bioasis to Attend Upcoming Industry Conferences 138

6.81 Sep 29, 2021: Novacyt Announces Annual General Meeting 139

6.82 Sep 29, 2021: Novacyt Notice of AGM 139

6.83 Sep 27, 2021: Novacyt reports 1H results 140

6.84 Sep 27, 2021: Novacyt Announces unaudited results for the half year ended 30 June 2021 140

6.85 Sep 16, 2021: Lynette Jackson appointed as new head of communications at Siemens 141

6.86 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 142

6.87 Sep 14, 2021: EKF Diagnostics Holdings Announces unaudited interim results for the six months ended 30 June 2021 142

6.88 Sep 13, 2021: SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options 143

6.89 Sep 03, 2021: Ortho Clinical Diagnostics to Participate in September Investor Conferences 144

6.90 Sep 02, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences 144

6.91 Sep 01, 2021: BioMerieux announce First-Half 2021 Results 145

6.92 Sep 01, 2021: Biolidics Announces Re-designation of Interim Chief Executive Officer as Chief Scientific Officer 145

6.93 Sep 01, 2021: Biolidics Appointment of Director of Corporate Finance and Corporate Development 145

6.94 Sep 01, 2021: Biolidics Announces Appointment of Executive Director and Chief Executive Officer 145

6.95 Aug 23, 2021: SDI Group Posting of Annual Report and Notice of AGM 146

6.96 Aug 20, 2021: Novacyt Notice of AGM 146

6.97 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 146

6.98 Aug 18, 2021: BioPorto Announces Q2 2021 Report 148

6.99 Aug 16, 2021: Halo Collective releases Q2 2021 results 149

6.100 Aug 13, 2021: Biolidics’ Revenue Dipped to S$0.64 Million in the First Half of 2021 151

6.101 Aug 13, 2021: A multiplex TaqMan qPCR assay for detection and quantification of clade 1 and clade 2 isolates of Pseudoperonospora cubensis and Pseudoperonospora humuli 152

6.102 Aug 13, 2021: A novel multiplex qPCR method for assessing the comparative lengths of telomeres 154

6.103 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference 155

6.104 Aug 11, 2021: Span Divergent announces Result For The Quarter Ended On June 30, 2021 155

6.105 Aug 10, 2021: Horiba Reports Consolidated Financial Statements for the Six Months Ended June 30, 2021 156

6.106 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference 157

6.107 Aug 06, 2021: Sysmex Provides Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2022 157

6.108 Aug 05, 2021: Siemens Announces Excellent Results with Raised Guidance 159

6.109 Aug 04, 2021: Ortho Clinical Diagnostics Reports Second Quarter 2021 Results 161

6.110 Aug 04, 2021: Mitsubishi Chemical Holdings announces Financial Results Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 163

6.111 Aug 04, 2021: Mitsubishi Chemical Holdings Announces Notice Regarding Revision to Consolidated Financial Results Forecast for the First Half of Fiscal Year Ending March 31, 2022 163

6.112 Jul 29, 2021: Bio-Rad Reports Second-Quarter 2021 Financial Results 163

6.113 Jul 29, 2021: QIAGEN Reports Full Results for Q2 and H1 2021 164

6.114 Jul 29, 2021: BD to Present at UBS Genomics

2.0 and MedTech Innovations Summit 166

6.115 Jul 29, 2021: Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A 166

6.116 Jul 28, 2021: Hologic Announces Financial Results for Third Quarter of Fiscal 2021 167

6.117 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference 168

6.118 Jul 23, 2021: Ortho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021 168

6.119 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results 168

6.120 Jul 19, 2021: Theradiag Reports Revenue of €5.5 Million for the First Half of 2021, Up

12.5% 169

6.121 Jul 01, 2021: Bioasis Announces the Appointment of Dave Jenkins as Chief Financial Officer 171

6.122 Jun 24, 2021: Mitsubishi Chemical Holdings announces Personnel Notice Regarding Executive Personnel Changes 171

6.123 Jun 23, 2021: Halo Collective Announces Results of Annual General and Special Meeting 172

6.124 Jun 22, 2021: Novacyt Full Year 2020 Results and Update on Growth Strategy 172

6.125 Jun 22, 2021: Novacyt Announces Full year 2020 results and update on growth strategy 184

6.126 Jun 16, 2021: Mitsubishi Chemical Announces Personnel Organizational Changes and Personnel Changes 184

6.127 Jun 14, 2021: Biolidics Announces Appointment of Ian David Brown as an Independent Director 185

6.128 Jun 11, 2021: Span Divergent announces Financial Results For The Year Ended On March 31, 2021 185

7 Appendix 186

7.1 Methodology 186

7.2 About GlobalData 188

7.3 Contact Us 189

7.4 Disclaimer 189

Table

Immunochemistry Analyzers – Pipeline Products by Stage of Development 14

Immunochemistry Analyzers – Pipeline Products by Segment 15

Immunochemistry Analyzers – Pipeline Products by Territory 16

Immunochemistry Analyzers – Pipeline Products by Regulatory Path 17

Immunochemistry Analyzers – Pipeline Products by Estimated Approval Date 18

Immunochemistry Analyzers Companies – Pipeline Products by Stage of Development 19

Immunochemistry Analyzers – Pipeline Products by Stage of Development 21

Astek Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

Eugris – Product Status 23

Eugris – Product Description 23

Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

Atolyzer Gene – Product Status 24

Atolyzer Gene – Product Description 24

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 25

UniCel DxN – Product Status 25

UniCel DxN – Product Description 25

Biosan Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

DNA And Protein Array Scanner System – Product Status 26

DNA And Protein Array Scanner System – Product Description 26

BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 27

DigiPLEX Analyzer – Product Status 27

DigiPLEX Analyzer – Product Description 27

Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 28

AFIAS-1 – Product Status 28

AFIAS-1 – Product Description 29

AFIAS-6 – Product Status 29

AFIAS-6 – Product Description 29

Ichroma – 10 Analyzer – Product Status 30

Ichroma – 10 Analyzer – Product Description 30

Ichroma III Analyzer – Product Status 30

Ichroma III Analyzer – Product Description 31

Ichroma M3 Analyzer – Product Status 31

Ichroma M3 Analyzer – Product Description 31

Boston University Pipeline Products & Ongoing Clinical Trials Overview 32

Lab-On-A-Chip – Thyroid Cancer – Product Status 32

Lab-On-A-Chip – Thyroid Cancer – Product Description 32

BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 33

BreviTest Robotic Analyzer – Product Status 33

BreviTest Robotic Analyzer – Product Description 33

China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34

SPR Analyzer – Product Status 34

SPR Analyzer – Product Description 34

ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 35

Handheld Tester – Malaria – Product Status 35

Handheld Tester – Malaria – Product Description 35

Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

AssayQuest – Product Status 36

AssayQuest – Product Description 36

Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 37

ELISA Microplate Reader – Product Status 37

ELISA Microplate Reader – Product Description 37

DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 38

LIAISON XS Analyzer – Product Status 38

LIAISON XS Analyzer – Product Description 38

Drew Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

DS360 HbA1c Analyzer – Product Status 39

DS360 HbA1c Analyzer – Product Description 39

Dyamed Biotech Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

MicroKit AIO – Product Status 40

MicroKit AIO – Product Description 40

Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

Enigma XL System – Product Status 41

Enigma XL System – Product Description 41

Euroimmun AG Pipeline Products & Ongoing Clinical Trials Overview 42

RA Analyzer 10 – Product Status 42

RA Analyzer 10 – Product Description 43

Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 44

Micro-ELISA System – Product Status 44

Micro-ELISA System – Product Description 44

GenapSys Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Genapsys Benchtop Arrayed Chip System – 144 M and 1B+ Chips – Product Status 45

Genapsys Benchtop Arrayed Chip System – 144 M and 1B+ Chips – Product Description 45

Genapsys Benchtop Single Chip System – 144M – Product Status 46

Genapsys Benchtop Single Chip System – 144M – Product Description 46

Genapsys Integrated Modular System – 144 M and 1B+ Chips – Product Status 46

Genapsys Integrated Modular System – 144 M and 1B+ Chips – Product Description 47

Genevo Biosystems Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Genetic Molecular Analyzer – Product Status 48

Genetic Molecular Analyzer – Product Description 48

Great Basin Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

GB550 Analyzer – Product Status 49

GB550 Analyzer – Product Description 49

HeatFlow Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50

FireCycler – Product Status 50

FireCycler – Product Description 50

Hokkaido University Pipeline Products & Ongoing Clinical Trials Overview 51

Portable Fluorescence Polarization Analyzer – Product Status 51

Portable Fluorescence Polarization Analyzer – Product Description 51

Huakang Biomedical Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Semen Biochemical Immunoassay System – Product Status 52

Semen Biochemical Immunoassay System – Product Description 52

Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 53

Microfluidic Flow Analyzer – Product Status 53

Microfluidic Flow Analyzer – Product Description 53

Johnson & Johnson Pipeline Products & Ongoing Clinical Trials Overview 54

Optical Fluorescence Compact Desk-Top Instrument – Product Status 54

Optical Fluorescence Compact Desk-Top Instrument – Product Description 54

LabNow Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

CD4Now Analyzer – Product Status 55

CD4Now Analyzer – Product Description 55

Lucerna Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Portable Diagnostic Device – Sepsis – Product Status 56

Portable Diagnostic Device – Sepsis – Product Description 56

Magellan Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 57

PediaStat Analyzer – Product Status 57

PediaStat Analyzer – Product Description 57

MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58

MedNetic Assay System – Product Status 58

MedNetic Assay System – Product Description 58

Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 59

Next Generation Erenna System – Product Status 59

Next Generation Erenna System – Product Description 59

Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Project 24 – Product Status 60

Project 24 – Product Description 60

NanoLab Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Cardiac Marker Screening Device – Product Status 61

Cardiac Marker Screening Device – Product Description 61

Tumor Screening Device – Product Status 62

Tumor Screening Device – Product Description 62

Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 63

VITROS 3600 System With Power Processor – Product Status 63

VITROS 3600 System With Power Processor – Product Description 63

PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Accentis – Product Status 64

Accentis – Product Description 64

Protomex Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 65

Diagnose.IT – Product Status 65

Diagnose.IT – Product Description 65

Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Evidence Investigator Immunoassay Analyzer – Product Status 66

Evidence Investigator Immunoassay Analyzer – Product Description 66

Rapid Diagnostek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67

IntelliProbe Immunosensor – Product Status 67

IntelliProbe Immunosensor – Product Description 67

Siloam Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

Immunodiagnostic System – Product Status 68

Immunodiagnostic System – Product Description 68

Spectradyne LLC Pipeline Products & Ongoing Clinical Trials Overview 69

nCS1 Nanoparticle Analyzer – Product Status 69

nCS1 Nanoparticle Analyzer – Product Description 69

Tecan Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

Next Generation Molecular Diagnostics Platfiorm – Product Status 70

Next Generation Molecular Diagnostics Platfiorm – Product Description 70

The Palo Alto Research Center Pipeline Products & Ongoing Clinical Trials Overview 71

Handheld HIV Detector – Product Status 71

Handheld HIV Detector – Product Description 71

Tyncbest Biotechnology Pipeline Products & Ongoing Clinical Trials Overview 72

Pleural Micro Fluidic Analyzer – Product Status 72

Pleural Micro Fluidic Analyzer – Product Description 72

University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview 73

TRI Analyzer – Product Status 73

TRI Analyzer – Product Description 73

University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 74

Sepsis System – Product Status 74

Sepsis System – Product Description 74

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 75

Microfluid Device – Product Status 75

Microfluid Device – Product Description 75

University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 76

Multi-Phase Single Cell Analyzer – Product Status 76

Multi-Phase Single Cell Analyzer – Product Description 76

Virogenomics BioDevelopment Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Electrochemical Diagnostic Device – Product Status 77

Electrochemical Diagnostic Device – Product Description 77

Xanthostat Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Xanthostat Point-Of-Care Device – Product Status 78

Xanthostat Point-Of-Care Device – Product Description 78

Yunnan Energy International Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

Automatic Immunoassay System – Product Status 79

Automatic Immunoassay System – Product Description 79

Glossary 188

Figures

Immunochemistry Analyzers – Pipeline Products by Stage of Development 14

Immunochemistry Analyzers – Pipeline Products by Segment 15

Immunochemistry Analyzers – Pipeline Products by Territory 16

Immunochemistry Analyzers – Pipeline Products by Regulatory Path 17

Immunochemistry Analyzers – Pipeline Products by Estimated Approval Date 18

Frequently asked questions

Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more